about
SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycleSENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylationAnimal models of polyglutamine diseases and therapeutic approachesSumoylation in Synaptic Function and DysfunctionSUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease?Direct and/or Indirect Roles for SUMO in Modulating Alpha-Synuclein ToxicityBeyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1SUMO1 Affects Synaptic Function, Spine Density and MemoryStrategies to Identify Recognition Signals and Targets of SUMOylation.SUMOhydro: a novel method for the prediction of sumoylation sites based on hydrophobic propertiesSUMOylation Is an Inhibitory Constraint that Regulates the Prion-like Aggregation and Activity of CPEB3Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregationDisrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease.SUMO regulates the assembly and function of a cytoplasmic intermediate filament protein in C. elegansGlial contributions to neurodegeneration in tauopathies.SUMOylation in Giardia lamblia: A Conserved Post-Translational Modification in One of the Earliest Divergent Eukaryotes.SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stressMultiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chainsSUMO3 modification accelerates the aggregation of ALS-linked SOD1 mutants.Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicityUbiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implicationsSumoylation of bZIP transcription factor NRL modulates target gene expression during photoreceptor differentiation.SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity.SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.Cardiac function and disease: emerging role of small ubiquitin-related modifier.SUMO proteomics to decipher the SUMO-modified proteome regulated by various diseases.SUMO-mimicking peptides inhibiting protein SUMOylation.Mass spectrometric identification of novel lysine acetylation sites in huntingtinEnhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction.Protein SUMOylation modulates calcium influx and glutamate release from presynaptic terminalsPost-translational modifications of nuclear receptors and human diseaseModification and movement: Phosphorylation and SUMOylation regulate endocytosis of GluK2-containing kainate receptors.The emerging role of the first 17 amino acids of huntingtin in Huntington's diseaseOverexpression of SENP3 in oral squamous cell carcinoma and its association with differentiation.Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseasesEmerging extranuclear roles of protein SUMOylation in neuronal function and dysfunctionPathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.Acetylation within the First 17 Residues of Huntingtin Exon 1 Alters Aggregation and Lipid Binding.Strategies for the identification of novel inhibitors of deubiquitinating enzymes.SUMO and Alzheimer's disease.
P2860
Q24318317-A6ED1A3A-E300-4CB4-8688-1A4DE932E538Q24328747-69CA2A01-4D0E-457D-B8A0-1BCD71C256AAQ24655528-F132EE07-5DD3-4A03-B3C3-E985BE82D7BBQ26747536-75EE6B57-7C9D-4DB7-9A2D-9F068AF58FBEQ26783370-CC9FA7BA-8060-4C14-BAFB-EAB78A898E69Q26799306-6761AF03-7F76-435F-B4E6-4AC3745BE290Q27008548-F9A2729A-953E-4918-8C27-C7836F9FBA7BQ27308933-A52E158F-1741-440A-8334-09E7F7CB38A1Q27865263-7C67A696-B268-493B-A43A-F61DEE9AA7E4Q28480408-24D57359-6705-4EB4-82DB-4C5C10C15741Q28507433-8E28E55E-822A-41FF-A90F-FDB224BC07D6Q30377831-AC1A750A-824A-4B70-9384-F0BFB1C05E76Q30405382-716279C4-A833-4CEF-9E41-69E67F2AEAF2Q30492693-93295D5A-6CD3-4FEA-9961-2B23039B6DFBQ32173558-F6E26FD9-3265-42F6-826B-54FF3F59A1A6Q33649471-FB962184-AB55-42A7-ADE5-15500C6AB4A7Q33800141-4615DFC9-593D-4022-9106-CE42423E2760Q33812891-6FD6AAEC-6403-4756-A0A1-49F06E388077Q33817594-50742DFE-1CA5-4E1C-B0A5-B88F7E6D3092Q34003885-82C61EB1-C2F3-41D8-9AF1-262405C36EE9Q34012297-1C18473F-BD65-4B21-83F0-9BF87C4E5324Q34055928-1A75E9BC-9E60-4385-842C-5CA3B3E43CF5Q34575362-4CFE0D0B-2CF0-45F8-94D8-C93570662637Q34581013-196ACEB7-1B45-4740-8BA5-700C520C5812Q35032636-3B3F56CE-BC6D-48DB-B175-D7E92745C4B4Q35245641-3CCC950F-E191-44C5-A2A8-7AE07D2C1B88Q35440501-A4BF5A6C-FECA-4540-9FB2-A743F7B977FCQ35497667-D44295AE-2E31-4DB4-87F1-BB7BBFC01BC0Q35803643-DD346570-9185-49C1-9156-ECA0C7F4DC03Q35842627-B10A04D0-D05C-4352-85DF-EFB0AB0F4AE3Q35842790-2591E947-FD13-4F57-A35B-11E6D86E59A1Q36034996-FABBDCC2-6951-42D0-9361-9BA098D6E52AQ36110838-124EC4F6-62B7-4276-BE30-02953E4546E5Q36858606-C1322270-6AA1-4976-8E29-3840E2A445E5Q36974613-4EB72D99-B54D-4126-A0DF-B9F92EDE8B15Q36995104-F799FA9E-AB1E-4F6E-9FFD-248A3868DD72Q37065788-BBAE6372-A6D2-49D3-91CD-773DE88E88DBQ37142133-9E6B1782-238F-4CBD-A302-35A1B3009596Q37269483-B476B040-69A4-40B0-8989-7B3800B07ED1Q37297379-5B7865D3-3F71-4986-BFDA-A2175F0EE74C
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
SUMO on the road to neurodegeneration.
@ast
SUMO on the road to neurodegeneration.
@en
type
label
SUMO on the road to neurodegeneration.
@ast
SUMO on the road to neurodegeneration.
@en
prefLabel
SUMO on the road to neurodegeneration.
@ast
SUMO on the road to neurodegeneration.
@en
P1476
SUMO on the road to neurodegeneration.
@en
P2093
Paul E Fraser
Véronique Dorval
P304
P356
10.1016/J.BBAMCR.2007.03.017
P407
P577
2007-03-30T00:00:00Z